SMTL ID : 3v6o.2 (1 other biounit)

Leptin Receptor-antibody complex

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.95 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x CYS: CYSTEINE(Non-covalent)

CYS.1: 1 residues within 4Å: Chain A: C.177 No protein-ligand interaction detected (PLIP)

18 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 4 residues within 4Å: Chain A: P.75, I.76, F.77 Chain B: D.32 Ligand excluded by PLIP EDO.3: 5 residues within 4Å: Chain A: N.139, N.140, R.188, L.189, D.190 Ligand excluded by PLIP EDO.4: 3 residues within 4Å: Chain A: S.106, G.193, Y.194 Ligand excluded by PLIP EDO.5: 2 residues within 4Å: Chain A: C.46, D.48 Ligand excluded by PLIP EDO.6: 3 residues within 4Å: Chain A: P.50, T.100, C.101 Ligand excluded by PLIP EDO.8: 8 residues within 4Å: Chain B: Q.40, K.44, G.45, L.46 Chain C: D.86, F.88, G.100, S.101 Ligand excluded by PLIP EDO.9: 6 residues within 4Å: Chain B: D.100, D.106, Y.107 Ligands: ACT.7, ACT.17, EDO.21 Ligand excluded by PLIP EDO.10: 4 residues within 4Å: Chain B: K.4, L.6, T.24, S.26 Ligand excluded by PLIP EDO.11: 5 residues within 4Å: Chain B: V.3, K.4, L.5, Y.107, W.108 Ligand excluded by PLIP EDO.12: 6 residues within 4Å: Chain B: F.60, F.64, K.65, S.66, R.67, L.68 Ligand excluded by PLIP EDO.13: 5 residues within 4Å: Chain B: S.125, V.126, Y.127, K.213 Chain C: E.124 Ligand excluded by PLIP EDO.14: 7 residues within 4Å: Chain B: P.42, T.91, A.92, S.113, V.114, T.115, E.153 Ligand excluded by PLIP EDO.18: 3 residues within 4Å: Chain B: Y.107 Chain C: H.56, T.57 Ligand excluded by PLIP EDO.19: 3 residues within 4Å: Chain B: A.134 Chain C: S.209, N.211 Ligand excluded by PLIP EDO.20: 2 residues within 4Å: Chain C: S.53, N.54 Ligand excluded by PLIP EDO.21: 5 residues within 4Å: Chain C: F.50, R.55, T.57 Ligands: EDO.9, ACT.17 Ligand excluded by PLIP EDO.22: 8 residues within 4Å: Chain B: L.146, T.181, S.183 Chain C: L.161, S.163, S.177, S.178, T.179 Ligand excluded by PLIP EDO.23: 4 residues within 4Å: Chain B: P.131 Chain C: S.117, I.118, F.119 Ligand excluded by PLIP

3 x ACT: ACETATE ION(Non-functional Binders)

ACT.7: 8 residues within 4Å: Chain A: R.41, F.77 Chain B: D.33, K.98, D.100, G.101, D.106 Ligands: EDO.9 6 PLIP interactions: 2 interactions with chain A, 4 interactions with chain B Hydrophobic interactions: A:F.77 Salt bridges: A:R.41, B:K.98 Hydrogen bonds: B:G.101 Water bridges: B:D.33, B:D.33 ACT.16: 5 residues within 4Å: Chain C: Q.38, K.40, Q.46, P.60, F.63 5 PLIP interactions: 5 interactions with chain C Hydrogen bonds: C:Q.38, C:Q.46, C:Q.46 Water bridges: C:K.40 Salt bridges: C:K.40 ACT.17: 7 residues within 4Å: Chain B: D.100, D.106 Chain C: F.50, H.56, T.57 Ligands: EDO.9, EDO.21 4 PLIP interactions: 4 interactions with chain C Hydrophobic interactions: C:F.50 Hydrogen bonds: C:T.57, C:T.57 Salt bridges: C:H.56

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.15: 2 residues within 4Å: Chain C: R.19, N.21 1 PLIP interactions: 1 interactions with chain C Hydrogen bonds: C:T.73

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Carpenter, B. et al., Structure of the human obesity receptor leptin-binding domain reveals the mechanism of leptin antagonism by a monoclonal antibody. Structure (2012)

Release Date

2012-03-14

Peptides

Leptin receptor: A
Monoclonal antibody 9F8 fab fragment Heavy chain: B
Monoclonal antibody 9F8 fab fragment Light chain: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

B
D

C
F

Leptin receptor

Monoclonal antibody 9F8 fab fragment Heavy chain

Monoclonal antibody 9F8 fab fragment Light chain

Related Entries With Identical Sequence